BXP vs EDIT
Boston Properties Inc (BXP) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
BXP currently screens at market cap $12.12B. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the BXP and EDIT stock pages for the full models.
Not investment advice.